Correlation Between Spyre Therapeutics and ANTHOL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and ANTHOL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and ANTHOL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and ANTHOL 395 15 JUL 26, you can compare the effects of market volatilities on Spyre Therapeutics and ANTHOL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of ANTHOL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and ANTHOL.

Diversification Opportunities for Spyre Therapeutics and ANTHOL

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Spyre and ANTHOL is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and ANTHOL 395 15 JUL 26 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANTHOL 5 15 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with ANTHOL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANTHOL 5 15 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and ANTHOL go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and ANTHOL

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the ANTHOL. In addition to that, Spyre Therapeutics is 16.74 times more volatile than ANTHOL 395 15 JUL 26. It trades about -0.03 of its total potential returns per unit of risk. ANTHOL 395 15 JUL 26 is currently generating about 0.3 per unit of volatility. If you would invest  9,477  in ANTHOL 395 15 JUL 26 on September 1, 2024 and sell it today you would earn a total of  217.00  from holding ANTHOL 395 15 JUL 26 or generate 2.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy23.02%
ValuesDaily Returns

Spyre Therapeutics  vs.  ANTHOL 395 15 JUL 26

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
ANTHOL 5 15 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ANTHOL 395 15 JUL 26 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ANTHOL is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Spyre Therapeutics and ANTHOL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and ANTHOL

The main advantage of trading using opposite Spyre Therapeutics and ANTHOL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, ANTHOL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANTHOL will offset losses from the drop in ANTHOL's long position.
The idea behind Spyre Therapeutics and ANTHOL 395 15 JUL 26 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments